These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30228827)

  • 1. Association Rule Analysis for Validating Interrelationships of Combined Medication of Compound Kushen Injection in Treating Colon Carcinoma: A Hospital Information System-Based Real-World Study.
    Yang H; Xie Y; Ni J; Liu Y; Song R; Chen C; Zhuang Y; Zhang Y
    Evid Based Complement Alternat Med; 2018; 2018():4579801. PubMed ID: 30228827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association rules analysis of Fufang Kushen injection in combination with modern medications in treating lung cancer: real-world study based on hospital information].
    Yang HS; Xie YM; Chen C; Zhuang Y; Zhang Y
    Zhongguo Zhong Yao Za Zhi; 2018 Apr; 43(8):1708-1713. PubMed ID: 29751720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association rules analysis for exploring combined medication characteristics of Fufang Kushen injection: real-world study based on 49 597 cases].
    Zhang Y; Xie YM; Li YN; Zhang C; Chen C; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2900-2904. PubMed ID: 29139255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical application features of Fufang Kushen injection in treating malignant esophageal tumor： real world study based on hospital information system].
    Liu YX; Wang ZF; Xie YM; Zhang Y; Chen C; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2877-2882. PubMed ID: 29139251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical application characteristics of Ciwujia Injection in treatment of 5 904 cases with cardiovascular disease in real world].
    Sha JY; Liu H; Xie YM; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(15):3525-3532. PubMed ID: 32893540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer.
    Liu X; Wu Y; Zhang Y; Bu D; Wu C; Lu S; Huang Z; Song Y; Zhao Y; Guo F; Ye P; Fu C; Shen L; Zhang J; Wang H; Duan X; Wu J
    Front Oncol; 2021; 11():747300. PubMed ID: 34604090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association rules analysis of Fufang Kushen injection in combination with traditional Chinese medicine or modern medications in treating malignant tumor: real-world retrospective study].
    Zhang Y; Xie YM; Chen C; Zhang C; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(2):378-384. PubMed ID: 28948747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Advanced Systems Pharmacology Strategy Reveals
    Zhou W; Wu C; Zhao C; Huang Z; Lu S; Fan X; Tan Y; Stalin A; You R; Liu X; Zhang J; Wu Z; Wu J
    Front Cell Dev Biol; 2021; 9():742421. PubMed ID: 34646828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection With Transcriptome Analysis.
    Shen H; Qu Z; Harata-Lee Y; Aung TN; Cui J; Wang W; Kortschak RD; Adelson DL
    Front Oncol; 2019; 9():632. PubMed ID: 31380274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis.
    Wu X; Lu Y; Qin X
    J Ethnopharmacol; 2022 Jan; 283():114690. PubMed ID: 34597653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation.
    Wu C; Huang ZH; Meng ZQ; Fan XT; Lu S; Tan YY; You LM; Huang JQ; Stalin A; Ye PZ; Wu ZS; Zhang JY; Liu XK; Zhou W; Zhang XM; Wu JR
    Chin Med; 2021 Nov; 16(1):121. PubMed ID: 34809653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Compound Kushen Injection, a Natural Compound Mixture, and Its Identified Chemical Components on Migration and Invasion of Colon, Brain, and Breast Cancer Cell Lines.
    Nourmohammadi S; Aung TN; Cui J; Pei JV; De Ieso ML; Harata-Lee Y; Qu Z; Adelson DL; Yool AJ
    Front Oncol; 2019; 9():314. PubMed ID: 31106149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound Kushen Injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-Myc signaling.
    Wang KX; Du GH; Qin XM; Gao L
    Phytomedicine; 2021 Dec; 93():153781. PubMed ID: 34649212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
    Zhang LH; Zhang WY; Xiong JM; Duan XM; Hai LN; Zhang YL; Zhang MM; Qin GF; Zhang GW
    Chin J Nat Med; 2022 Jan; 20(1):43-53. PubMed ID: 35101249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound Kushen Injection Induces Immediate Hypersensitivity Reaction Through Promoting the Production of Platelet-Activating Factor via
    Gao Y; Hai L; Kang Y; Qin W; Liu F; Cai R; Yang X; Qi Y
    Front Pharmacol; 2021; 12():768643. PubMed ID: 34690789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine.
    Liang S; Li Y; Zhang X; Guo Y; Pan S
    Anticancer Agents Med Chem; 2021; 21(15):2012-2022. PubMed ID: 33573576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Real world study on characteristics of Maixuekang Capsules combined with traditional Chinese medicines in treating nephrotic syndrome].
    Lyu J; Xie YM; Wang ZF; Zhang YL; Chen RB; Zhang WL; Jia PP
    Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1668-1673. PubMed ID: 31090333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive effect of compound Kushen Injection to chemotherapy for non-small cell lung cancer: An evidence map and overview of systematic reviews.
    Yu ZY; Peng RY; Han M; Grant S; Yang GY; Liu JP; Cao HJ
    J Ethnopharmacol; 2021 Dec; 281():114538. PubMed ID: 34418510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Core prescription excavation of launched Chinese patent medicines for treating different syndromes of angina pectoris].
    Wei PL; Gu H; Guan S; Su YY; Liu Q; Liu J; Wang Z
    Zhongguo Zhong Yao Za Zhi; 2019 Mar; 44(5):1041-1047. PubMed ID: 30989867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.